AI & Automation · via TechCrunch AI

Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

3h ago · curated by Catalyst Web Trendz

The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.

This is a curated summary. The full story was reported by TechCrunch AI.

Read the full story at TechCrunch AI

Put this to work

What it means for your brand.

Stories like this are exactly the terrain we work in every day. If this trend touches your growth plans, these are the services to look at:

Related headlines.

TechCrunch AIjust now

Anthropic says its biology lab has already found something big

But maybe the biggest reveal is that Anthropic has not let Claude run loose in its biology lab. Humans are still, so far, in the loop.

Read on our site

TechCrunch AI6h ago

ChatGPT mobile app gets voice-based agentic features

Pro and Plus users will be able to use the Work tab on their phones to complete agentic tasks.

Read on our site

TechCrunch AI6h ago

Even Americans who use AI every day are worried about it

The report suggests that greater exposure will not resolve the unease around the technology, nor reduce public support for AI regulation.

Read on our site

All of today's digest